| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,357,063 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$69,327,006 |
|
|
| Total
Shares |
11,357,063 |
|
|
| Total
Value |
$69,327,006 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
8
|
|
Stock
price went up :
|
64
|
1
|
| Stock
price went down : |
59
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.1
|
| Percentage
Gain/Loss : |
 15.1%
|
 -143.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-22 |
123,750 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-16 |
4 |
S |
$4.86 |
$60,472 |
I/I |
(12,438) |
85,000 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-11-17 |
4 |
S |
$4.67 |
$116,713 |
I/I |
(25,000) |
2,375,000 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-12-06 |
4 |
S |
$1.44 |
$2,216 |
I/I |
(1,539) |
4,010,000 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-12-30 |
4 |
S |
$2.71 |
$41,949 |
I/I |
(15,473) |
130,000 |
0 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2023-11-10 |
4 |
S |
$0.29 |
$1,401,571 |
I/I |
(4,764,008) |
0 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-09 |
4 |
S |
$3.09 |
$94,526 |
I/I |
(30,600) |
2,531,994 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-10 |
4 |
S |
$3.11 |
$472,424 |
I/I |
(151,700) |
2,380,294 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-17 |
4 |
S |
$3.06 |
$230,326 |
I/I |
(70,885) |
126,050 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-21 |
4 |
S |
$3.06 |
$100,838 |
I/I |
(33,000) |
124,250 |
0 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2024-05-22 |
4 |
S |
$3.00 |
$29,596 |
I/I |
(9,800) |
123,750 |
0 |
% |
|
160 Records found
|
|
Page 7 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
